John Deaton, MD

Dr. John Deaton is a leading expert in microbial and enzyme research with more than 17 years in the nutraceutical industry. Before joining Biohm Technologies, he was VP of R&D for North America at ADM/Deerland Probiotics & Enzymes, driving innovations across market segments. His microbiome expertise spans spores, enzymes, and bacteriophages, backed by a Ph.D. in Biochemistry from Texas A&M and post-graduate work in microbiology, biophysics, and cancer research.

A published scientist with two PNAS papers and a cover feature in Archives of Biochemistry and Biophysics, Dr. Deaton is a long-standing member of key industry organizations, including the Global Prebiotics Association and the International Probiotics Association.